{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:53:42Z","timestamp":1767149622588,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/j.virol.2015.06.003","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000}}],"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R21AI100195"],"award-info":[{"award-number":["1R21AI100195"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.virol.2015.06.003","type":"journal-article","created":{"date-parts":[[2015,6,20]],"date-time":"2015-06-20T02:00:37Z","timestamp":1434765637000},"page":"163-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["RETRACTED: Immunogenicity of Newcastle disease virus vectors expressing Norwalk virus capsid protein in the presence or absence of VP2 protein"],"prefix":"10.1016","volume":"484","author":[{"given":"Shin-Hee","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim Y.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siba K.","family":"Samal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2015.06.003_bib1","series-title":"A Laboratory Manual for the Isolation and Identification of Avian Pathogens","first-page":"114","article-title":"Newcastle disease","author":"Alexander","year":"1989"},{"key":"10.1016\/j.virol.2015.06.003_bib2","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1056\/NEJMoa1101245","article-title":"Norovirus vaccine against experimental human Norwalk virus illness","volume":"365","author":"Atmar","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2015.06.003_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0016-5085(99)70548-2","article-title":"Recombinant Norwalk virus-like particles given orally to volunteers: phase I study","volume":"117","author":"Ball","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.virol.2015.06.003_bib4","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1128\/JVI.76.6.3023-3030.2002","article-title":"Expression and self-assembly of Norwalk virus capsid protein from venezuelan equine encephalitis virus replicons","volume":"76","author":"Baric","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.06.003_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJMoa065368","article-title":"Live attenuated versus inactivated influenza vaccine in infants and young children","volume":"356","author":"Belshe","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2015.06.003_bib6","doi-asserted-by":"crossref","first-page":"11603","DOI":"10.1128\/JVI.77.21.11603-11615.2003","article-title":"The 3\u2032 end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein","volume":"77","author":"Bertolotti-Ciarlet","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.06.003_bib7","doi-asserted-by":"crossref","first-page":"13275","DOI":"10.1128\/JVI.79.21.13275-13284.2005","article-title":"Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates","volume":"79","author":"Bukreyev","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.06.003_bib8","first-page":"46","article-title":"Newcastle disease virus as a vaccine vector for humans","volume":"10","author":"Bukreyev","year":"2008","journal-title":"Curr. Opin. Mol. Ther."},{"key":"10.1016\/j.virol.2015.06.003_bib9","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1086\/657087","article-title":"Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues","volume":"202","author":"El-Kamary","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.virol.2015.06.003_bib10","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1086\/315579","article-title":"Norwalk virus vaccines: challenges and progress","volume":"181","author":"Estes","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2015.06.003_bib11","doi-asserted-by":"crossref","first-page":"e63269","DOI":"10.1371\/journal.pone.0063269","article-title":"Norovirus P particle efficiently elicits innate, humoral and cellular immunity","volume":"8","author":"Fang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2015.06.003_bib12","doi-asserted-by":"crossref","first-page":"4827","DOI":"10.1128\/JVI.78.9.4827-4837.2004","article-title":"Norwalk virus N-terminal nonstructural protein is associated with disassembly of the Golgi complex in transfected cells","volume":"78","author":"Fernandez-Vega","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.06.003_bib13","series-title":"Fields virology","first-page":"582","article-title":"Caliciviridae: the noroviruses","author":"Green","year":"2013"},{"key":"10.1016\/j.virol.2015.06.003_bib14","doi-asserted-by":"crossref","first-page":"9713","DOI":"10.1128\/JVI.75.20.9713-9722.2001","article-title":"Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses","volume":"75","author":"Guerrero","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.06.003_bib15","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.vaccine.2007.11.039","article-title":"Intranasal administration of a recombinant adenovirus expressing the norovirus capsid protein stimulates specific humoral, mucosal, and cellular immune responses in mice","volume":"26","author":"Guo","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2015.06.003_bib16","doi-asserted-by":"crossref","first-page":"12335","DOI":"10.1128\/JVI.76.23.12335-12343.2002","article-title":"Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice","volume":"76","author":"Harrington","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.06.003_bib17","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1099\/0022-1317-82-7-1729","article-title":"High-level expression of a foreign gene from the 3\u2032 proximal first locus of a recombinant Newcastle disease virus","volume":"82","author":"Huang","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2015.06.003_bib18","doi-asserted-by":"crossref","first-page":"6527","DOI":"10.1128\/JVI.66.11.6527-6532.1992","article-title":"Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein","volume":"66","author":"Jiang","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.06.003_bib19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1126\/science.1257147","article-title":"Enteric bacteria promote human and mouse norovirus infection of B cells","volume":"346","author":"Jones","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.virol.2015.06.003_bib20","doi-asserted-by":"crossref","first-page":"9718","DOI":"10.1128\/JVI.01570-14","article-title":"Newcastle disease virus vector producing human norovirus-like particles induces serum, cellular, and mucosal immune responses in mice","volume":"88","author":"Kim","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.06.003_bib21","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1128\/JVI.79.5.2900-2909.2005","article-title":"Cellular and humoral immunity following Snow Mountain virus challenge","volume":"79","author":"Lindesmith","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.06.003_bib22","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1128\/JVI.06200-11","article-title":"Monoclonal antibody-based antigenic mapping of norovirus GII.4-2002","volume":"86","author":"Lindesmith","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.06.003_bib23","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1016\/j.vaccine.2006.03.080","article-title":"Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains","volume":"24","author":"LoBue","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2015.06.003_bib24","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1128\/JVI.02332-10","article-title":"Vesicular stomatitis virus as a vector to deliver virus-like particles of human norovirus: a new vaccine candidate against an important noncultivable virus","volume":"85","author":"Ma","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2015.06.003_bib25","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1017\/S0950268812000234","article-title":"The epidemiology of published norovirus outbreaks: a review of risk factors associated with attack rate and genogroup","volume":"140","author":"Matthews","year":"2012","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.virol.2015.06.003_bib26","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1016\/j.vaccine.2012.03.050","article-title":"Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations","volume":"30","author":"Parra","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2015.06.003_bib27","doi-asserted-by":"crossref","first-page":"e67592","DOI":"10.1371\/journal.pone.0067592","article-title":"Identification of a broadly cross-reactive epitope in the inner shell of the norovirus capsid","volume":"8","author":"Parra","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2015.06.003_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MOG.0000000000000022","article-title":"Epidemiology of human noroviruses and updates on vaccine development","volume":"30","author":"Ramani","year":"2014","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.virol.2015.06.003_bib30","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1086\/656364","article-title":"Serological correlate of protection against norovirus-induced gastroenteritis","volume":"202","author":"Reeck","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2015.06.003_bib31","series-title":"The Biology of Paramyxoviruses","first-page":"69","article-title":"Newcastle disease and related avian paramyxoviruses","author":"Samal","year":"2011"},{"key":"10.1016\/j.virol.2015.06.003_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3201\/eid1701.P11101","article-title":"Foodborne illness acquired in the United States-major pathogens","volume":"17","author":"Scallan","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2015.06.003_bib33","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1128\/JVI.03508-12","article-title":"Norwalk virus minor capsid protein VP2 associates within the VP1 shell domain","volume":"87","author":"Vongpunsawad","year":"2013","journal-title":"J. Virol."}],"updated-by":[{"DOI":"10.1016\/j.virol.2021.03.001","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T00:00:00Z","timestamp":1615420800000},"record-id":"26590"},{"DOI":"10.1016\/j.virol.2021.03.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000}},{"DOI":"10.1016\/j.virol.2015.06.003","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000}}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682215002792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682215002792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:32:09Z","timestamp":1758587529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682215002792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":32,"alternative-id":["S0042682215002792"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2015.06.003","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Immunogenicity of Newcastle disease virus vectors expressing Norwalk virus capsid protein in the presence or absence of VP2 protein","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2015.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}